Targeted Axillary Dissection Does Benefit Patients with a Single Positive Node Prior to Neoadjuvant Chemotherapy

被引:0
|
作者
Ragunathan, Janani [1 ]
Ledwidge, Serena [2 ]
机构
[1] Queen Mary Univ London, London, England
[2] St Bartholomews Hosp, London, England
关键词
D O I
10.1093/bjs/znad258.211
中图分类号
R61 [外科手术学];
学科分类号
摘要
353
引用
收藏
页数:1
相关论文
共 50 条
  • [41] Nomogram Predicting Axillary Lymph Node Dissection Omission After Neoadjuvant Chemotherapy for Node-positive Breast Cancer
    Seki, Hirohito
    Ishiguro, Yuki
    Makino, Akitsugu
    Yamaguchi, Kei
    Imoto, Shigeru
    ANTICANCER RESEARCH, 2024, 44 (11) : 5131 - 5138
  • [42] Accurate axillary lymph node dissection is feasible after neoadjuvant chemotherapy
    Straver, Marieke E.
    Rutgers, Emiel J. T.
    Oldenburg, Hester S. A.
    Wesseling, Jelle
    Linn, Sabine C.
    Russell, Nicola S.
    Peeters, Marie-Jeanne T. F. D. Vrancken
    AMERICAN JOURNAL OF SURGERY, 2009, 198 (01): : 46 - 50
  • [43] Radiation after axillary lymph node dissection: impact of neoadjuvant chemotherapy
    Kirstein, L. J.
    MacDonald, S.
    Abi Raad, R.
    Taghian, A. G.
    Smith, B. L.
    Specht, M. C.
    BREAST CANCER RESEARCH AND TREATMENT, 2007, 106 : S240 - S240
  • [44] Targeted Axillary Lymph Node Dissections Using Radar Reflector Localization Can Reduce Unnecessary Axillary Lymph Node Dissections in Node Positive Patients Treated with Neoadjuvant Chemotherapy
    Lunt, Lilia
    Coogan, Alison
    Madrigrano, Andrea
    O'Donoghue, Cristina
    CANCER RESEARCH, 2023, 83 (05)
  • [45] Node-Positive Patients Treated with Neoadjuvant Chemotherapy Can Be Spared Axillary Lymph Node Dissection with Wireless Non-Radioactive Localizers
    Alison Laws
    Kayla Dillon
    Bridget N. Kelly
    Olga Kantor
    Kevin S. Hughes
    Michele A. Gadd
    Barbara L. Smith
    Leslie R. Lamb
    Michelle Specht
    Annals of Surgical Oncology, 2020, 27 : 4819 - 4827
  • [46] Evidence-Based Strategies to Minimize the Likelihood of Axillary Lymph Node Dissection in Clinically Node-Positive Patients Following Neoadjuvant Chemotherapy
    Woodfin, Ashley A.
    Caudle, Abigail S.
    SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA, 2023, 32 (04) : 693 - 703
  • [47] Node-Positive Patients Treated with Neoadjuvant Chemotherapy Can Be Spared Axillary Lymph Node Dissection with Wireless Non-Radioactive Localizers
    Laws, Alison
    Dillon, Kayla
    Kelly, Bridget N.
    Kantor, Olga
    Hughes, Kevin S.
    Gadd, Michele A.
    Smith, Barbara L.
    Lamb, Leslie R.
    Specht, Michelle
    ANNALS OF SURGICAL ONCOLOGY, 2020, 27 (12) : 4819 - 4827
  • [48] Evaluation of traditional targeted axillary dissection eligibility criteria for node-positive breast cancer after neoadjuvant chemotherapy in a prospective multicenter registry
    -Jones, Catherine Loveland
    Gaughan, John
    Caudle, Abigail
    Murphy, Brittany
    Samiian, Laila
    Byrum, Stephanie
    Brill, Kristen
    Germaine, Pauline
    Zhang, Xinmin
    Yoon-Flannery, Kay
    Carter, Teralyn
    Lopez, Adrian
    Gruner, Ryan
    Fantazzio, Michele
    Kuerer, Henry
    EJSO, 2024, 50 (04):
  • [49] A nomogram to predict axillary response to neoadjuvant chemotherapy in clinically node positive breast patients
    Vila, Jose
    Bassett, Roland L.
    Mittendorf, Elizabeth Ann
    Bedrosian, Isabelle
    Shaitelman, Simona Flora
    Stauder, Michael Charles
    Chavez-Mac Gregor, Mariana
    Litton, Jennifer Keating
    Yang, Wei Tse
    Huo, Lei
    Kuerer, Henry Mark
    Hunt, Kelly
    Caudle, Abigail Suzanne
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [50] Evolution of Axillary Surgery for Node Positive Breast Cancer Patients Treated with Neoadjuvant Chemotherapy
    Nguyen, T. T.
    Hoskin, T.
    Day, C.
    Hieken, T. J.
    Boughey, J. C.
    ANNALS OF SURGICAL ONCOLOGY, 2017, 24 : S64 - S65